Cardiovascular
FDA approves treatment for HIV-linked abdominal fat
November 11, 2010 9:35 am | by Mass High Tech: The Journal of New England Technology | News | CommentsThe U.S. Food and Drug Administration has approved a treatment, developed by Canadian firm Theratechnologies and marketed exclusively in the U.S. by Rockland-based EMD Serono, for excess abdominal fat in HIV-infected patients with lipodystrophy.
New Analyses of Data From RE-LY Trial, Involving Oral Anticoagulant Pradaxa, to be Presented at American Heart Association's Scientific Sessions
November 11, 2010 9:35 am | by Bio-Medicine.Org | News | CommentsRIDGEFIELD, Conn., Nov. 11, 2010 /- Results of two pre-specified sub-study analyses of the 18,113 patient RE-LY® trial,(1) involving the newly approved oral anticoagulant Pradaxa® (dabigatran etexilate mesylate) capsules,(2) will be presented at the American Heart Association's...
Thoratec Announces Webcast of Investor Presentation at American Heart Association Meeting
November 11, 2010 5:35 am | by Bio-Medicine.Org | News | CommentsPLEASANTON, Calif., Nov. 11, 2010 /- Thoratec Corporation (Nasdaq: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be hosting an investor event on Tuesday, November 16 at the American Heart...
Scripps, Kaiser Sign Deal to Collaborate
November 10, 2010 4:34 pm | by San Diego Business Journal | News | CommentsScripps Health and Kaiser Permanente have signed a 10-year comprehensive agreement for Scripps to provide cardiac surgery, interventional cardiology and bariatric services to more than 500,000 Kaiser members across San Diego County.
JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing
November 10, 2010 4:34 pm | by Bio-Medicine.Org | News | CommentsWASHINGTON, Nov. 10, 2010 /PRNewswire-USNewswire/ -- Diabetes experts at a meeting convened by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) took the next step in advancing efforts toward the development of an artificial pancreas: putting forth...
Stereotaxis Receives Commitment to Increase and Extend Credit Facility
November 10, 2010 4:34 pm | by Bio-Medicine.Org | News | CommentsST. LOUIS, Nov. 10, 2010 /- Stereotaxis, Inc. (Nasdaq: STXS ) announced today that the Company has received a commitment letter from Silicon Valley Bank for an amended credit agreement that extends its revolving $30 million credit facility to March 31, 2012. Consistent with the...
Obesity and Diabetes Are Increasing in Cats
November 10, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsST. JOSEPH, Mo., Nov. 10, 2010 /- Diabetes isn’t just a human disease. This November – American Diabetes Month® – pet owners should know that the feline members of their families could suffer from the condition, too. Type 2 diabetes is the most common form in the...
China Cord Blood Corporation Commences Warrant Exchange Offer
November 10, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsHONG KONG, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO ) ("CCBC" or "the Company"), the first and largest cord blood bank operator in China, today commenced its previously announced warrant exchange offer, and provided warrant holders with...
SIGVARIS Provides 'Red Socks' to Honor Efforts by Boston Red Sox Manager, Terry Francona, to Raise Awareness for DVT Prevention
November 10, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsPEACHTREE CITY, Ga., Nov. 10, 2010 /- SIGVARIS, the global leader in medical compression therapy, has teamed up with the North American Thrombosis Forum and Boston Red Sox Manager and blood clot survivor, Terry Francona, to raise awareness about the dangers of blood clots. Did you know...
Lotus Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2010 Financial Results
November 10, 2010 4:32 am | by Bio-Medicine.Org | News | CommentsBEIJING, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS ) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that it...
Abaxis, Inc. to Present at Stephens Fall Investment Conference
November 9, 2010 4:35 am | by Bio-Medicine.Org | News | CommentsUNION CITY, Calif., Nov. 9, 2010 /- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, announced today that Donald Wood, chief operations officer, will present at the Stephens Fall Investment Conference on Wednesday, November 17,...
Twilight of the Blood Draws?
November 8, 2010 7:33 pm | by Massachusetts Institute of Technology | News | CommentsA new technique lets doctors screen drops of dried blood rather than vials of the liquid. The method could revolutionize infant pharmacology and drug testing for athletes.
Data Presented at ACR Meeting Demonstrate Safety of Colcrys® (Colchicine, USP) for Treatment of Gout Flares in Patients with Multiple Co-Morbid Conditions
November 8, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsATLANTA, Nov. 8, 2010 /- Patients who experience gout flares can be treated safely with Colcrys® (colchicine, USP), even in the presence of co-morbid conditions that often present physicians with treatment challenges, according to a new analysis presented here at the 74th Annual...
EXTENSION, INC. to Launch Apple iPhone Application for Use in Clinical Workflows
November 8, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsFORT WAYNE, Ind., Nov. 8, 2010 /- EXTENSION, INC . announced today that in addition to its Cisco IP device integration, it will make available for general release to the healthcare community the EXTENSION for Apple iPhone application . EXTENSION's existing offerings use Cisco IP devices...
Harvard's headache cure: LSD?
November 7, 2010 8:34 pm | by Mass High Tech: The Journal of New England Technology | News | CommentsMove over, Advil. Harvard Medical School researcher John Halpern says LSD, the hallucinogen at the heart of the 1960s drug counterculture, holds a better treatment for cluster headaches, and he's formed a company he hopes will bring to market a drug based on his research.
United American Healthcare Corporation Announces Senior Management Appointments and Relocation to Chicago
November 5, 2010 5:32 am | by Bio-Medicine.Org | News | CommentsDETROIT, Nov. 5, 2010 /- United American Healthcare Corporation (OTCQB: UAHC) today announced that its Board of Directors has approved key appointments to the Company's senior management team. UAHC management also announced that the Company will relocate its headquarters from...
Biogen ends collaboration with Cardiokine
November 4, 2010 12:35 pm | by Mass High Tech: The Journal of New England Technology | News | CommentsBiogen Idec Inc. and its Philadelphia-based partner Cardiokine Inc. have ended a collaboration on lixivaptan, a drug candidate for hyponatremia, or low sodium levels in the blood.
ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China
November 4, 2010 12:34 pm | by Bio-Medicine.Org | News | CommentsRANCHO CORDOVA, Calif., Nov. 4, 2010 /- ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative products and services that process and store adult stem cells, said today it has signed a distribution agreement covering China and Hong Kong for its products used to prepare cell...
Gentris Corporation Names New Chief Scientific Advisor
November 4, 2010 12:34 pm | by Bio-Medicine.Org | News | CommentsMORRISVILLE, N.C., Nov. 4, 2010 /- Gentris Corporation ( www.gentris.com ), a global leader in applied clinical pharmacogenomics, announced today that Howard McLeod, Pharm.D., from The University of North Carolina at Chapel Hill (UNC) has become the Company's first Chief Scientific...
FDA Reclassifies Certain Digital Mammography Devices
November 4, 2010 9:35 am | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md., Nov. 4, 2010 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced that it is easing the pathway to market for mammography systems that produce computerized X-ray images of the entire breast. (Logo: ...
AccuVein Receives Grant for its Award Winning AV300 Vein Illumination System
November 4, 2010 9:34 am | by Bio-Medicine.Org | News | CommentsCOLD SPRING HARBOR, N.Y., Nov. 4, 2010 /- AccuVein LLC, the developer of the first non-contact, handheld vein illumination system, announced today that it had been awarded the maximum grant amount from the Qualifying Therapeutic Discover Project (QTDP) program. This Federal grant...
Biogen Idec to Close San Diego Site
November 3, 2010 11:31 pm | by San Diego Business Journal | News | CommentsBiogen Idec Inc., one of the world's largest makers of multiple sclerosis drugs, said Nov. 3 that it was restructuring its operations by closing its San Diego site along with two other facilities in Massachusetts.
Georgia Tech Hosts Sickle Cell Disease Symposium
November 3, 2010 8:34 am | by Georgia Tech Institute of Technology | News | CommentsGeorgia Tech will host the Sickle Cell Disease Symposium bringing together researchers, policy experts and community advocates to discuss the latest research and strategies for future success in combating this complex and debilitating blood disorder.
IDEV Technologies Announces FDA 510(k) Clearance for SUPERA VERITASâ„¢
November 3, 2010 3:33 am | by Bio-Medicine.Org | News | CommentsWEBSTER, Texas, Nov. 3, 2010 /- IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance to market the SUPERA VERITAS...
Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in...
November 2, 2010 7:33 pm | by Bio-Medicine.Org | News | CommentsBASKING RIDGE, N.J., Nov. 2, 2010 /- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Steven L. Zelenkofske, D.O., F.A.C.C., Senior Vice President and Chief Medical Officer, presented an...
